These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 2871050

  • 21. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 22. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 23. The efficacy and safety of alprazolam versus other benzodiazepines in the treatment of panic disorder.
    Moylan S, Staples J, Ward SA, Rogerson J, Stein DJ, Berk M.
    J Clin Psychopharmacol; 2011 Oct; 31(5):647-52. PubMed ID: 21869686
    [Abstract] [Full Text] [Related]

  • 24. Platelet serotonin uptake in panic disorder: comparison with normal controls and the effect of treatment.
    Norman TR, Gregory MS, Judd FK, Burrows GD, McIntyre IM.
    Aust N Z J Psychiatry; 1988 Dec; 22(4):390-5. PubMed ID: 2907288
    [Abstract] [Full Text] [Related]

  • 25. Effect of alprazolam and diazepam on anxiety and panic attacks in panic disorder: a controlled study.
    Dunner DL, Ishiki D, Avery DH, Wilson LG, Hyde TS.
    J Clin Psychiatry; 1986 Sep; 47(9):458-60. PubMed ID: 2875064
    [Abstract] [Full Text] [Related]

  • 26. Alprazolam in the treatment of generalized anxiety and panic disorders: a double-blind placebo-controlled study.
    Chouinard G, Annable L, Fontaine R, Solyom L.
    Psychopharmacology (Berl); 1982 Sep; 77(3):229-33. PubMed ID: 6126907
    [Abstract] [Full Text] [Related]

  • 27. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. II. Patient acceptance, side effects, and safety.
    Noyes R, DuPont RL, Pecknold JC, Rifkin A, Rubin RT, Swinson RP, Ballenger JC, Burrows GD.
    Arch Gen Psychiatry; 1988 May; 45(5):423-8. PubMed ID: 3358644
    [Abstract] [Full Text] [Related]

  • 28. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 May; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 29. Fading of therapeutic effects of alprazolam in agoraphobia. Case reports.
    Fava GA.
    Prog Neuropsychopharmacol Biol Psychiatry; 1988 May; 12(1):109-12. PubMed ID: 3363164
    [Abstract] [Full Text] [Related]

  • 30. Neuroendocrine correlates of lactate-induced anxiety and their response to chronic alprazolam therapy.
    Carr DB, Sheehan DV, Surman OS, Coleman JH, Greenblatt DJ, Heninger GR, Jones KJ, Levine PH, Watkins WD.
    Am J Psychiatry; 1986 Apr; 143(4):483-94. PubMed ID: 2869703
    [Abstract] [Full Text] [Related]

  • 31. Clonazepam in the treatment of panic disorder and agoraphobia.
    Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS.
    Psychopharmacol Bull; 1987 Apr; 23(1):141-4. PubMed ID: 3110854
    [No Abstract] [Full Text] [Related]

  • 32. Three cases of panic disorder with agoraphobia in children.
    Ballenger JC, Carek DJ, Steele JJ, Cornish-McTighe D.
    Am J Psychiatry; 1989 Jul; 146(7):922-4. PubMed ID: 2742019
    [Abstract] [Full Text] [Related]

  • 33. Discontinuation reactions to alprazolam in panic disorder.
    Pecknold JC.
    J Psychiatr Res; 1993 Jul; 27 Suppl 1():155-70. PubMed ID: 8145176
    [Abstract] [Full Text] [Related]

  • 34. Cognitive style, alprazolam plasma levels, and treatment response in panic disorder.
    Uhlenhuth EH, Starcevic V, Qualls C, Antal EJ, Matuzas W, Javaid JI, Barnhill J.
    Depress Anxiety; 2008 Jul; 25(8):E18-26. PubMed ID: 17960759
    [Abstract] [Full Text] [Related]

  • 35. Panic disorder may respond to new 'antidepressants'.
    González ER.
    JAMA; 1982 Dec 17; 248(23):3077-8, 3086-7. PubMed ID: 6128433
    [No Abstract] [Full Text] [Related]

  • 36. Alprazolam kinetics in the elderly. Relation to antipyrine disposition.
    Greenblatt DJ, Divoll M, Abernethy DR, Moschitto LJ, Smith RB, Shader RI.
    Arch Gen Psychiatry; 1983 Mar 17; 40(3):287-90. PubMed ID: 6131657
    [Abstract] [Full Text] [Related]

  • 37. Reduction in hypochondriasis with treatment of panic disorder.
    Noyes R, Reich J, Clancy J, O'Gorman TW.
    Br J Psychiatry; 1986 Nov 17; 149():631-5. PubMed ID: 3814956
    [Abstract] [Full Text] [Related]

  • 38. Efficacy of benzodiazepines in panic disorder and agoraphobia.
    Ballenger JC.
    J Psychiatr Res; 1990 Nov 17; 24 Suppl 2():15-25. PubMed ID: 1980694
    [Abstract] [Full Text] [Related]

  • 39. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov 17; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 40. Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.
    Lopez AL, Kathol RG, Noyes R.
    Psychoneuroendocrinology; 1990 Nov 17; 15(1):23-8. PubMed ID: 2367614
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.